Delivery Order SPE2DE24D0013-SPE2D625F8ST9
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The...
- The Defense Department's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as delivery order XPCOV2/FLU/RSV-10, is scheduled for completion by August 6, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,096.80 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 14, 2025. This firm fixed-price delivery order, designated 4569108553 and titled "XPCOV2/FLU/RSV-10," is scheduled for completion by August 28, 2025, with performance taking place at the contractor's Sunnyvale facility. The award carries no set-aside designation and represents procurement of molecular...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, designated 4568960200 for XPCOV2/FLU/RSV-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order designation suggests this award was issued under a larger indefinite delivery vehicle (IDV) contract, consistent...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8ST9Delivery Order
The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts with the Veterans Integrated Service Network, reflecting the company's established position as a primary supplier of molecular diagnostic systems and reagents to federal healthcare agencies. Cepheid, a for-profit manufacturer specializing in advanced diagnostic systems including its GeneXpert platform, maintains significant federal presence through multiple contracts with the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The award carries no set-aside designation, indicating full and open competition. With an expedited completion timeline of less than one week, this delivery order represents a focused procurement of diagnostic capabilities for infectious disease detection within the defense health supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 7/25/25 |